The prospects for new treatments for prostate cancer
- 1 January 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 52 (1) , 3-5
- https://doi.org/10.1016/s0360-3016(01)02665-7
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissueInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Is the α/β ratio for prostate cancer low?International Journal of Radiation Oncology*Biology*Physics, 2001
- A simple analytic derivation suggests that prostate cancer α/β ratio is lowInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Is α/β for prostate tumors really low?International Journal of Radiation Oncology*Biology*Physics, 2001
- Toward optimal external-beam fractionation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Letters to the editorInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont Phase II dose-escalating trialInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trialsRadiotherapy and Oncology, 1999
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Time-dose factors in radiotherapy: a review of the human dataRadiotherapy and Oncology, 1990